Requires health plans to cover generic opioid antagonists and devices starting January 1, 2027.

Hawaii HB1767 mandates that health plans, including hospital or medical service plans, health maintenance organizations, and accident and health or sickness insurance policies, must cover at least one generic opioid antagonist and device starting January 1, 2027. These generic medications and devices must be placed on the lowest cost-sharing tier, without annual or lifetime dollar limitations, and must comply with the Mental Health Parity and Addiction Equity Act of 2008. Prior authorization is not required for generic forms, though it may be needed for non-generic forms.

Requires health plans to cover generic opioid antagonists and devices starting January 1, 2027.

Hawaii HB1767 mandates that health plans, including hospital or medical service plans, health maintenance organizations, and accident and health or sickness insurance policies, must cover at least one generic opioid antagonist and device starting January 1, 2027. These generic medications and devices must be placed on the lowest cost-sharing tier, without annual or lifetime dollar limitations, and must comply with the Mental Health Parity and Addiction Equity Act of 2008. Prior authorization is not required for generic forms, though it may be needed for non-generic forms.